Trials / Terminated
TerminatedNCT02190552
Analysis of Revascularisation in Ischemic Stroke With EmboTrap
A.R.I.S.E. Analysis of Revascularisation in Ischemic Stroke With EmboTrap: Post Marketing Observational Study of CE Marked EmboTrap Mechanical Thrombectomy Device
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 40 (actual)
- Sponsor
- Neuravi Limited · Industry
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
A.R.I.S.E. is a post approval observational study using standard care. The purpose of this study is to collect information about the ability of the EmboTrap device to remove blood clots from the brain, and the associated performance characteristics and clinical outcomes. No formal hypothesis testing is needed as no comparisons are planned within the study. Instead, estimates of each population parameter of interest for all primary and secondary endpoints will be provided using appropriate confidence intervals.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | EmboTrap® Revascularization Device |
Timeline
- Start date
- 2014-11-01
- Primary completion
- 2016-05-01
- Completion
- 2018-01-01
- First posted
- 2014-07-15
- Last updated
- 2019-03-11
- Results posted
- 2019-03-11
Locations
5 sites across 5 countries: Denmark, Germany, Ireland, Spain, Sweden
Source: ClinicalTrials.gov record NCT02190552. Inclusion in this directory is not an endorsement.